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Abstract
Background: To evaluate the clinical outcomes after the implantation of a new trifocal diffractive intraocular lens
(IOL) combined with Enhanced depth of focus (EDOF) technology.
Methods: The study enrolled 80 eyes of 40 patients who underwent cataract surgery with bilateral implantation of
a diffractive trifocal IOL (Reviol Tri-ED) designed with a combination of enhanced depth of focus. Mean age was 52.
09 ± 11.32 years (range from 45 to 70 years). Uncorrected distance visual acuity (UDVA), corrected distance visual
acuity (CDVA), uncorrected intermediate visual acuity (UIVA), corrected intermediate visual acuity (CIVA), uncorrected
near visual acuity (UNVA), corrected near visual acuity (CNVA), keratometry (K), and manifest refraction spherical
equivalent (MRSE) were evaluated pre- and postoperatively. The contrast sensitivity, defocus curves, and a
questionnaire evaluating individual satisfaction were also estimated.
Results: There was a significant improvement in UDVA, CDVA, UNVA, CNVA, CIVA postoperatively. The defocus
curve confirmed good visual acuity also in the intermediate distance. The postoperative MRSE was ranged from −0.
75 to 0.75 diopters. Contrast sensitivity also significantly improved postoperatively. The patient satisfaction was high.
Conclusion: The new trifocal EDOF IOL provides visual improvement for far, intermediate, and near distances with
a high level of visual quality and patient satisfaction.
Keywords: Enhanced depth of focus, Intraocular lens, Trifocal
Background
Cataract, which is a treatable problem, is the leading
cause of vision disorders and blindness all over the
world [1]. Although aging is the primary cause of
cataract, other factors associated with cataract formation
include various diseases, trauma, medications and gen-
etic predisposition. While the prevalence of visually
significant cataract is about 2.5% at the age of 40–49
years, it increases with age and reaches to 68% before
the age of 80 years [2]. The most frequent application in
the surgical treatment of cataract is implantation of
monofocal or multifocal intraocular lenses (IOLs) after re-
moval of opacified lenses using phacoemulsification [2].
The use of IOLs aims at providing good and high-
quality vision and reducing need for additional optical
correction. Additionally, designs of monofocal IOLs
allow either near or distance focus. In order to overcome
this limitation, multifocal IOLs with refractive, diffract-
ive, and the combination of both optical principles have
been developed [3]. Multifocal IOLs can improve uncor-
rected near visual acuity (UNVA) and uncorrected
distance visual acuity (UDVA). Nevertheless, different
IOL models provide different levels of improvement for
uncorrected intermediate visual acuity (UIVA). Various
collateral effects such as halos, glare and loss of contrast
sensitivity may be observed with the use of multifocal
IOLs [4]. Many domestic and professional tasks includ-
ing the use of computers require a good intermediate
vision. While bifocal lenses cause difficulty in intermedi-
ate vision, trifocal lenses provide an increase in inter-
mediate vision without compromising distance and near
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vision [3]. Trifocal IOL models have recently been intro-
duced and clinical outcomes have been reported in the
literature. Technical properties of a new lens (Acriva
Reviol Tri-ED), particularly enhanced depth of focus
property, seem encouraging; thus, we used it in a group
of patients and wish the present the initial results, which
may be followed by comparative studies in the future.
The present study aimed to evaluate visual acuities
(distance, intermediate and near), refractive changes,
contrast sensitivity, defocus curve, and postoperative
satisfaction of a new diffractive trifocal IOL (Acriva
Reviol Tri-ED).
Subjects and methods
This prospective study comprised of bilateral cataract or
presbyopia/pre-presbyopia suitable for refractive lens
exchange patients who underwent routine phacoemulci-
fication with diffractive trifocal IOL implantation be-
tween the periods of August 2014 and July 2015 at the
Haydarpasa Numune Education and Research Hospital,
Ophthalmology Clinic, Istanbul, Turkey. Informed con-
sents of the patients were obtained. The study adhered
to the tenets of the Declaration of Helsinki and was
approved by the local ethics committee. Inclusion cri-
teria were patients with bilateral cataract or presbyopia/
pre-presbyopia suitable for refractive lens exchange and
seeking for spectacle independence. Exclusion criteria
were a history of glaucoma or retinal detachment, cor-
neal disease, regular corneal astigmatism greater 0.75D,
irregular corneal astigmatism, abnormal iris, macular
degeneration or retinopathy, neurophthalmic disease, his-
tory of ocular inflammation and previous ocular surgery.
In the preoperative period, the following evaluations
were performed: Distance (6 m, Early Treatment of
Diabetic Retinopathy Study [ETDRS]), intermediate
(80 cm) and near (40 cm) VA with and without correction,
slit lamp examination, applanation tonometry, corneal
topography (Sirius 3D, CSO, Italy), dilated fundus examin-
ation, optical biometry (IOLMaster version 4.3, Carl Zeiss
Meditec AG, Germany) using SRK/T formula. The cata-
racts were graded using the LOCS III classification by the
same examiner after slit-lamp examination [5].
All surgeries were performed by the same experienced
surgeon (BTA) using a standard technique of sutureless
microcoaxial 1.8–2.2 mm phacoemulsification. All inci-
sions were made at the steep axis of the cornea. A
1.8 mm incision was made and 1.8 mm injector was
used. In case of difficulty, the incision was extended up
to 2.2 mm. After capsulorhexis creation and phacoemul-
sification, the IOLs were inserted into the capsular bag
using the Acrijet Blue injector (VSY Biotechnology,
Amsterdam, Netherlands) through the main incision.
Postoperatively, all patients received the same treatment:
a combination of an antibiotic and steroid agent.
The tests used in the preoperative period were also
performed at the1st, 3rd and 6th months, except contrast
sensitivity. Contrast sensitivity was evaluated preopera-
tively and at month 6, and measurement was performed
under photopic (85 candelas [cd]/m2) conditions (CSV-
1000, VectorVision, Ohio, USA). For the evaluation of the
defocus curve, patients wore the correction providing the
distance visual acuity in both eyes and the ETDRS charts
were used at a distance of 4 m. Different levels of defocus
were introduced in 0.5 D steps from +1.50 D to 4.00 D,
and visual acuity values were recorded.
In order to evaluate patient satisfaction, the VFQ-14
(14-item Visual Function Questionnaire) was admi-
nistered to the patients via e-mail at the postoperative
6th month. VFQ-14 questionnaire was sent via e-mail
and patients were asked to respond within one week.
Patients that did not respond until the specified deadline
were called by phone and reminded about the question-
naire. Finally, all patients responded. To avoid patients
being influenced, they answered the questions on their
own. The questionnaire consists of 14 questions cover-
ing 14 aspects of visual function [6]. Each item was
scored between 0 and 4 points, highest total point being
56. The degree of difficulty experienced while perform-
ing activities related to vision was assessed as no diffi-
culty (4 points), a little difficulty (3 points), a moderate
amount of difficulty (2 points), a great deal of difficulty
(1 point), and unable to do the activity (0 point). The
average of the points was calculated; higher points indi-
cate a less difficulty in performing activities. In addition,
all patients were questioned on spectacle need and
photic phenomena during the 6th month visit.
The Acriva Reviol Tri-ED is an IOL with a single piece
diffractive trifocal EDOF design (Fig. 1). The characteris-
tics of the IOL is presented on the Table 1.
Product features are defined in manufacturer’s docu-
ments [7]. The EDOF feature of the lens provides a dif-
ferent advantage from the other available trifocal IOLs.
Trifocal EDOF combination was created by changing
Fig. 1 The new model of trifocal diffractive intraocular lens, Acriva
Reviol Tri-ED
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height, width, interval and number of the diffractive rings.
It’s a semi-apodized active diffractive trifocal structure is
designed to reduce unwanted diffraction to increase op-
tical quality with enhanced depth of focus vision. The
entire optic dimeter covers 25 diffractive rings. This IOL
has a trifocal anterior surface and provides an addition of
3.00 D for near and 1.50 D for intermediate at the IOL
plane. Its design allocates 44% of light to distance, 28% to
intermediate, and 28% to near for photopic and mesopic
light condition; its overall efficiency of global light trans-
mittance is 89.1%. The IOL is fully pupil diameters inde-
pendent and provides adequate visual performance under
all lighting conditions. It has a plate-haptic design with no
haptic angulation with all enhanced 360-degree square
edge to prevent posterior capsule opacification formation.
It has spherical powers of 0.00 D to C32.00 D in 0.50 D
increments and is implanted with a single-use injector
through 2.2 mm incision.
Statistical analysis
NCSS (Number Cruncher Statistical System) 2007&PASS
(Power Analysis and Sample Size) 2008 Statistical Soft-
ware (Utah, USA) programs were used for statistical
analyses. In addition to the descriptive statistics (mean,
standard deviation, median, frequency, ratio, minimum,
maximum), quantitative data were evaluated also by
Friedman Test for intragroup comparison and Wilcoxon
signed-rank test for paired comparison of the parameters
that were not distributed normally. Categorical variables
were compared using chi-square test. The surgically
induced astigmatism (SIA) was defined as the vector of
change in corneal astigmatism between the preoperative
and postoperative period. Corneal astigmatism data,
obtained by corneal topography, were transformed into
Cartesian (x and y) coordinates and surgically induced
astigmatism (SIA) was calculated using a standard vec-
tor analysis. After the calculations were finished, the
Cartesian coordinates were transformed back to the
standard notation for astigmatism (cylinder and merid-
ian). Statistical significance was evaluated at the levels
of p < 0.01 and p < 0.05.
Results
The present study included 40 patients who underwent
bilateral trifocal IOL implantation. Patient characteristics
are summarized in Table 2. The mean nuclear opales-
cence grade was 3.2 (range 1.2 to 4.1) for the 35 patients
operated for cataract.
Visual acuity
Visual acuities over time are demonstrated in Table 3
and Fig. 2. Statistically significant difference was deter-
mined between preoperative values and postoperative
6th-month values of UDVA, UIVA and UNVA. Uncor-
rected variables showed significant improvement after
surgery as compared to the preoperative values.
Keratometry
The results of keratometry are demonstrated in Table 4. No
significant difference was determined between preoperative
values and postoperative 6th-month values in terms of the
flattest meridian (Kf), steepest meridian (Ks) and kerato-
metric astigmatism (Ks-Kf). According to vector analysis,
the mean surgically induced astigmatism based on kerato-
metry data was −0.23 ± 0.18 D (range, [−0.02]-[−1.00 D]).
Refraction
Refractive changes of the patients over time are demon-
strated in Table 4. Significant decrease was determined
in the spherical and spherical equivalent values.
Table 1 General IOL parameters [7]
Parameters Reviol Tri-ED 611
Material Hydrophobic surface, acrylic with
25% water content, blue filter
Optic size 6.00 mm
Optic design Active-Diffractive Tri-ED
Haptic size 11.00 mm
Haptic Design Plate Haptic
Haptic Angle 0°
Recommended Ac. A Constant 118.0
Recommended Op. A Constant Srk-T: 118.3 – SRK-II: 118.5
Diopter Power Range From 0.0 D to +32.00 D
(0.50 D increments)
Refractive Index Dry 20 °C/35 °C 1.509/1.509 ± 0.002












IOL intraocular lens, D diopter, PCO posterior capsule opacification
Table 2 Patient characteristics
Parameters




Age, years, mean ± SD, (range) 52.09 ± 11.32 (45–70)
Follow-up, months, mean ± SD 9.2 ± 2.1
SD standard deviation
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Contrast sensitivity
The results of contrast sensitivity over time at 4 different
spatial frequencies are depicted in Fig. 3. From 1 month
to 6 months postoperatively, there was a slight but sig-
nificant improvement in contrast sensitivity at 3 cpd
(spatial frequency). The mean contrast sensitivity chan-
ged from 1.78 ± 0.20 log units to 1.83 ± 0.11 log units
(p = 0.023). There was no significant improvement in
contrast sensitivity at 6 cpd, 12 cpd, and 18 cpd be-
tween 1 month and 6 months postoperatively.
Defocus curve
The mean visual acuities and their standard deviations
for different defocus values are demonstrated in Fig. 4.
In the present study, defocus curve obtained by trifocal
IOL showed a tendency of flattening different from the
Table 3 LogMar visual acuity changes over time
Visual acuity Preoperative 1 M 3 M 6 M P value*
UDVA
Mean ± SD 0,72 ± 0,20 −0,03 ± 0,08 −0,04 ± 0,08 −0,04 ± 0,08 0.001
Range 0,4–0,9 −0,2–0,2 −0,2–0,2 −0,2–0,2
CDVA
Mean ± SD 0,05 ± 0,18 −0,05 ± 0,05 −0,05 ± 0,05 −0,05 ± 0,08 0,018
Range 0,0–0,5 −0,2–0,2 −0,2–0,2 −0,2–0,2
UNVA
Mean ± SD 0,76 ± 0,16 0,22 ± 0,13 0,18 ± 0,13 0,15 ± 0,12 0,001
Range 0,4–1,4 −0,1–0,5 0,0–0,5 0,0–0,5
CNVA
Mean ± SD 0,28 ± 0,18 0,21 ± 0,12 0,16 ± 0,11 0,13 ± 0,04 0,340
Range 0,0–0,8 −0,1–0,5 0,0–0,3 0,0–0,4
UIVA
Mean ± SD 0,69 ± 0,18 0,08 ± 0,12 0,10 ± 0,10 0,08 ± 0,11 0,001
Range 0,1–1,2 −0,1–0,5 −0,1–0,4 −0,1–0,4
CIVA
Mean ± SD 0,15 ± 0,2 0,06 ± 0,07 0,07 ± 0,08 0,06 ± 0,10 0,120
Range 0,0–0,5 −0,1–0,4 −0,1–0,4 −0,1–0,4
UDVA uncorrected distance visual acuity, CDVA corrected distance visual
UNVA uncorrected near visual acuity acuity, CNVA corrected near visual acuity
UIVA uncorrected intermediate visual acuity, CIVA corrected intermediate visual acuity, SD standard deviation, M month
*6 month vs. preoperative measurement
Fig. 2 Visual acuity outcomes for distance (6 m), intermediate (80 cm), near (40 cm) distances during the whole period of follow up. (UDVA= uncorrected
distance visual acuity; CDVA= corrected distance visual acuity; UIVA = uncorrected intermediate visual acuity; CIVA = corrected intermediate visual acuity;
UNVA = uncorrected near visual acuity; CNVA= corrected near visual acuity)
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typical M-shape observed by bifocal IOL. VA was pre-
served particularly in intermediate distances.
Patient satisfaction
The results of the questionnaire applied at the postopera-
tive 6th month are summarized in Table 5. More than 90%
of the patients reported no difficulty in performing the daily
activities related to vision. The average total score (sum of
all questions) was 54.6, 55.1, and 51.0 over maximum score
of 56 for the whole study group (n = 40), patients operated
for cataract (n = 35), and patients operated for presbyopia/
pre-presbyopia (n = 5), respectively. When item-based
responses are considered, 95% (464/490) of total questions
were scored 4 (no difficulty) in the cataract group, whereas
the corresponding figure was 74% (52/70) in the presby-
opia/pre-presbyopia group (p < 0.001), indicating higher
Table 4 Refractive and keratometric changes over time
Parameters Preoperative 1 M 3 M 6 M P value*
Sphere, D
Mean ± SD 0.40 ± 2.50 −0.10 ± 0.45 −0.00 ± 0.20 −0.02 ± 0.28 0.001
Range −6.00, 3.50 −0.75, 0.75 −0.0, 0.50 −0.75, 0.50
Cylinder, D
Mean ± SD −0.45 ± 0.36 0.35 ± 0.23 0.28 ± 0.13 0.28 ± 0.12 0.02
Range −0.75, 0.00 −0.75, 0.0 0.50, 0.50 0.50, 0.00
MRSE, D
Mean ± SD 0.70 ± 2.28 0.24 ± 0.42 0.16 ± 0.35 0.12 ± 0.31 0.001
Range −5.50, 3.25 −0.75, 0.75 −0.75, 0.50 −0.75, 0.75
K2, D
Mean ± SD 43.54 ± 1.52 43.46 ± 1.01 43.52 ± 1.12 43.48 ± 1.35 0.618
Range 40.43, 45.25 40.25, 45.48 40.21, 44.52 40.66, 45.51
K1, D
Mean ± SD 42.92 ± 1.28 42.86 ± 1.12 42.90 ± 1.34 42.88 ± 1.26 0,868
Range 39.75, 47.50 39.75, 45.00 39.75, 45.00 39.75, 45.00
K2-K1, D
Mean ± SD 0.62 ± 0.28 0.60 ± 0.25 0.62 ± 0.38 0.60 ± 0.38 0.612
Range −0.18, 0.14 −0.15, 1.22 −0.09, 1.15 −0.05, 1.24
MRSE manifest refraction spherical equivalent, D diopter, K1 flat keratometry reading, K2 steep keratometry reading, M month, K2-K1 corneal cylinder, SD
standard deviation
*6 month vs. preoperative measurement
Fig. 3 Mean contrast sensitivity outcomes under photopic conditions 6 months after the surgery with different spatial frequencies (cpd = cycles
per degree)
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satisfaction in cataract patients. In addition, none of the
patients complained of photic phenomena and were all
spectacle-free at the 6th month visit.
Complications
No serious complication (iridodialysis, posterior capsule
perforation, etc.) occurred during the surgery; refractive sur-
prise, postoperative macular edema and posterior capsule
opacity (PCO) were encountered during follow-up period.
Discussion
Recently, it is possible to obtain more successful out-
comes in the treatment of patients with cataract with
the developments in phacoemulsification techniques and
IOL technology. Providing high-quality VA and best
levels of spectacle independence for near, intermediate
and distance vision has been the primary aim after
multifocal IOL implantation [8, 9]. With the use of
bifocal IOL implantation, successful outcomes have been
Fig. 4 Defocus curve of Acriva Reviol Tri-ED intraocular lens
Table 5 The results of VFQ-14 Questionnaire performed to assess the patient satisfaction regarding the activities related to vision at
the postoperative 6th month





Mean ± SD n (%) n (%) n (%) n (%) n (%)
Reading small print 3.85 ± 042 35 (87.5) 4 (10.0) 1 (2.5) 0 (0.0) 0 (0.0)
Reading normal newsprint 3.95 ± 0.22 38 (95.0) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Reading large newsprint 3.97 ± 0.15 39 (97.5) 1 (2.5) 0 (0.0) 0 (0.0) 0 (0.0)
Recognizing faces at a distance 3.85 ± 0.48 36 (90.0) 2 (5.0) 2 (5.0) 0 (0.0) 0 (0.0)
Going downstairs 3.97 ± 0.15 39 (97.5) 1 (2.5) 0 (0.0) 0 (0.0) 0 (0.0)
Reading street signs 3.95 ± 0.22 38 (95.0) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Sewing, doing delicate manual work 3.80 ± 0.51 34 (85.0) 4 (10.0) 2 (5.0) 0 (0.0) 0 (0.0)
Reading mail, bills accurately 3.90 ± 0.37 37 (92.5) 2 (5.0) 1 (2.5) 0 (0.0) 0 (0.0)
Playing cards 3.95 ± 0.22 38 (95.0) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Going out to movies, plays, sporting events 3.95 ± 0.22 38 (95.0) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Cooking 3.90 ± 0.30 36 (90.0) 4 (10.0) 0 (0.0) 0 (0.0) 0 (0.0)
Watching television 3.95 ± 0.22 38 (95.0) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Driving on day 3.87 ± 0.40 36 (90.0) 3 (7.5) 1 (2.5) 0 (0.0) 0 (0.0)
Driving at night 3.75 ± 0.66 34 (85.0) 3 (7.5) 2 (5.0) 1 (2.5) 0 (0.0)
SD standard deviation
(no difficulty - 4 points; a little of difficulty - 3 points; moderate amount of difficulty – 2 points; a great deal of difficulty - 1 point; unable to do - 0)
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obtained in distance and near vision along with in-
creased quality of life and patient satisfaction; however,
intended level of improvement could not be achieved in
intermediate VA or different outcomes have been ob-
tained depending on characteristics of lens or on patient
selection [10–19]. In addition, some of the patients hav-
ing bifocal IOL implantation complain about certain
functional disorders such as haloes or rings around
lights, glare and photopsia [20, 21].
Trifocal IOLs, which have three focal spots, have been
introduced into use to overcome the problems experi-
enced with bifocal lenses. It has been reported that the
use of trifocal IOLs significantly improves intermediate
VA without impairing near and distance vision [22, 23].
This also enhances patient satisfaction with its favorable
effects on quality of life [22, 23].
Studies conducted on different commercial models of
trifocal IOLs have reported good distance, intermediate
and near VAs. In their study, Carballo-Alvarez et al. [24]
performed FineVision trifocal IOL implantation in 44
eyes of 22 patients with cataract and reported that a full
range of adequate vision was achieved, contrast sensitiv-
ity was satisfactory, and there were no significant ad-
verse photic phenomena after implantation. Sheppard et
al. [25] obtained good distance VA and near and in-
termediate visual function with the use of FineVision
trifocal IOL. In the patients (54 eyes of 27 patients) who
underwent AT LISA trifocal IOL implantation following
phacoemulsification, Kohnen et al. [26] reported good
distance, intermediate and near VAs (0.10 logMAR or
better), a high patient satisfaction, and a high spectacle
independence at the postoperative 3rd month. Kretz et
al. [27] reported significant improvements in UDVA,
UIVA, UNVA, and CDVA and better binocular out-
comes as compared with monocular outcomes in 100
eyes of 50 patients who underwent AT LISA IOL im-
plantation following cataract surgery.
In the present study, Acriva Reviol Tri-ED IOL was
implanted in 80 eyes of 40 patients. The UDVA, UIVA
and UNVA logMAR values were determined as 0.72 ±
0.20, 0.69 ± 0.18 and 0.76 ± 0.16, respectively, in the
preoperative period and as −0.04 ± 0.08, 0.08 ± 0.11 and
0.15 ± 0.12, respectively, at the postoperative 6th month.
These improvements in distance, intermediate and near
VAs were found to be significant (p = 0.001 for each).
The preoperative spherical equivalent refraction was
0.70 ± 2.28 D and a significant decrease to a value of
0.12 ± 0.31 D occurred at the postoperative 6th month.
These results suggested that the trifocal IOL used in the
present study was very effective. In their study, Vryghem
and Heireman [28] implanted FineVision trifocal IOL in
50 eyes of 25 patients and reported binocular UDVA,
UIVA and UNVA to be −0.04 ± 0.09, −010 ± 0.15 and
0.02 ± 0.06 logMAR, respectively, at the postoperative
6th month. In their study performed on 94 eyes of 47
patients, Cochener et al. [29] reported binocular UDVA,
UIVA and UNVA as 0.02 ± 0.09, 005 ± 0.08 and 0.00 ±
0.04 logMAR, respectively at the 6th month following
FineVision trifocal IOL implantation. Jonker et al. [30]
compared the Finevision Micro F trifocal IOL with the
Acrysof Restor IQ C3.0 D bifocal IOL in their random-
ized prospective study and indicated that better defocus
curve was obtained by trifocal IOL in the intermediate
distance. They also reported that the mean binocular
UDVA, UIVA, and UNVA were 0.01 ± 0.11 logMAR,
0.32 ± 0.15 logMAR, and 0.15 ± 0.13 logMAR, respect-
ively, in the patients implanted with trifocal IOL (30 eyes
of 15 patients) at the postoperative 6th month. Kretz et
al. [31] reported a binocular UDVA of 0.00 logMAR or
better and a binocular UIVA of 0.10 logMAR or better
in all patients undergoing AT LISA trifocal IOL implant-
ation (76 eyes of 38 patients), and a binocular UNVA of
0.10 logMAR or better in 85% of the patients at the post-
operative 3 months. Mojzis et al. [32] conducted a study
in the patients (120 eyes of 60 patients) who underwent
cataract surgery with trifocal AT LISA IOL implant-
ation; and followed the patients for a postoperative
period of 12- month. They reported that a complete
and stable visual restoration and good levels of visual
quality were achieved with the use of trifocal IOL dur-
ing the follow-up period.
In the present study, acceptable changes were observed
postoperatively in the keratometric parameters as com-
pared with the preoperative period. This finding was
consistent with the results of other studies performed with
trifocal IOLs [22, 27]. It seems that steep meridian inci-
sion may not have clinically relevant flattening effects and
small incision size may account for this outcome.
In the present study, the best levels of contrast sensi-
tivity were achieved at lower (3 cpd) spatial frequencies.
Likewise, Vryghem and Heireman [28] and Kretz et al.
[31] also achieved the highest level of contrast sensitivity
at 3 cpd. In the studies conducted by Mojzis et al. [22]
and Sheppard et al. [25], the contrast sensitivity curve
revealed that the patients had high sensitivity to medium
(6 cpd) spatial frequencies. However, in this study, no
change was observed at other spatial frequencies. Prob-
ably absence of a negative change at 6, 12 and 18 cpd
may also be interpreted as clinically relevant, possibly in-
dicating the absence of posterior capsular opacification.
In the present study, evaluation of the defocus curve ob-
tained at the postoperative 6th month revealed that inter-
mediate VA was also effectively improved in addition to
near and distance VAs. According to the results of the
questionnaire performed during the follow-up period,
most of the patients had no difficulty in performing
many activities related to vision and thus were satis-
fied with the results.
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We believe that the outcomes we achieved support the
idea that EDOF elements can be valuable option to be
used as IOLs to restore the imaging ability of the pseu-
dophakic eyes. Using this new design concept of IOLs
promises an expanded depth of field without the draw-
backs associated with a multifocal visual system. All our
patients achieved spectacle independence without an
incidence of photic phenomena, such as halos and glare
at 6 month-follow up.
Several EDOF-related technical features of Reviol Tri-
ED seem to provide some potential advantages: i) real
trifocal structure at both center and periphery in con-
trast to other available trifocal IOLs (e.g. Finevision is a
combination of two bifocal patterns and ATLisa has
trifocal structure at the center but bifocal at the outer
zone); ii) high modular transfer function (MTF) values
for transitions, aiding seamless continuous vision; iii) the
amount of light reaching retina is high and the ratios of
light distributed to far, near and intermediate sights are
similar resulting in better light utilization (other IOLs
send more light for far vision); iv) intermediate and near
sight additions are different thus potentially providing
better intermediate sight (80 cm); v) pupil-independent
due to semi-apodization feature; vi) higher Abbe value
than other IOLs thus providing better chromatic aberra-
tion control to prevent halo glare [33], vii) diffractive sur-
face transitions zones are smooth, possibly preventing
halo-glare and low contrast sensitivity. However, although
these features and findings of this study are encouraging,
further comparative studies with other trifocal IOLs are
warranted to examine whether these characteristics trans-
late into better clinical outcomes.
The limitations of our study are small number of eyes
included, also a reading speed is an important indicator
of near visual performance which was not estimated in
the current study. This might be also a limitation in
terms of assessing the functional vision.
Conclusions
Acriva Reviol Tri-ED used in the present study, a novel
trifocal IOL, appears to be a new option in overcoming
the problems experienced with bifocal lenses owing to
its maximum light energy transmission, and tolerability.
It is able to provide an effective distance, intermediate,
and near visual acuities after cataract surgery, with high
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